(S)-3-([1,1'-Biphenyl]-4-yl)-2-((tert-butoxycarbonyl)amino)propanoic acid, 95.0%, 1g

5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1,2-dihydroisoquinolin-1-one, 95+%, 1g

4-(4-(Bicyclo[2.2.1]heptan-2-yl)piperazin-1-yl)aniline (racemate), 97%, 1g

Weise buffer concentrate pH 6.8, 100 ml, 5 x 20 ml

Fmoc-D-Ala-OH.H2O, 97.0%, 10g

2,4-Dichloro-5,7-dimethyl-7H-pyrrolo[2,3-d]pyrimidine, 97%, 1g

2,2-DIMETHYL-6-NITRO-2H-BENZO[B][1,4]OXAZIN-3(4H)-ONE, 95.0%, 10g

(2Z)-but-2-enedioic acid; 3-ethyl 5-methyl 2-[(2-aminoethoxy)methylidene]-4-(2-chlorophenyl)-6-methyl-1,2,3,4-tetrahydropyridine-3,5-dicarboxylate, 95%, 100mg

Fmoc-D-Cha-OH, 97%, 5g

(4-(Cyclopropylmethoxy)phenyl)boronic acid, 95.0%, 1g

2,4-Dichloro-6-fluorobenzonitrile, 95.0%, 5g

1,3-Bis(4-methoxyphenyl)urea, 99.0%, 1g

4-amino-1H-pyrazole-5-carboxamide hydrochloride, 95.0%, 250mg